相关实验视频

Updated: May 5, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

聚多巴胺纳米颗粒集成智能小条纹多糖水凝:光热触发的CO2释放用于糖尿病伤口微环境调节

Xiao Wang¹, Zihao Ma¹, Yujie He¹

¹College of Pharmacy and Food, Southwest Minzu University, Chengdu & Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai Tibet Plateau, Chengdu, 610225, People's Republic of China.

International journal of nanomedicine

|July 14, 2025

概括

这项研究引入了一种新的水凝,当暴露在近红外光线下时会释放二氧化碳 (CO2),有效治疗糖尿病伤口. CO2@PDA水凝通过提高氧气水平,减少细菌和减少炎症来促进愈合.

科学领域:

生物材料科学生物材料科学
伤口治愈研究研究伤口治愈研究
纳米技术纳米技术

背景情况:

糖尿病伤口存在复杂的愈合挑战,原因是感染,氧化应激和不良血管化.
传统的带不足以处理这些复杂的伤口环境.
开发先进的材料对于改善糖尿病伤口修复至关重要.

研究的目的:

开发一种对光热有反应的水凝,用于增强糖尿病伤口愈合.
创建一种能够在近红外 (NIR) 激光照射时释放二氧化碳 (CO2) 的材料.
在糖尿病伤口模型中研究这种释放二氧化碳的水凝的治疗潜力.

主要方法:

制造一个含有二氧化碳生成的聚多巴胺纳米粒子 (CO2@PDA NP) 的碳素甲基Bletilla条纹多糖水凝.
使用DLS,SEM,FTIR和rheology等技术对纳米粒子和水凝特性进行表征.
对光热转化,二氧化碳释放,L929细胞增殖,对黄金葡萄球菌和大肠杆菌的抗菌活性以及对大鼠模型的体内疗效的评估.

主要成果:

在NIR激光 (808nm) 照射后,CO2@PDA水凝证明了有效的光热转换,导致局部CO2释放.
释放的二氧化碳刺激了波尔效应,缓解了缺氧并促进了伤口微环境中的血管生成.
水凝表现出抗菌,抗氧化和抗炎性质,显著改善了大鼠糖尿病伤口愈合.

结论:

开发的CO2@PDA水凝是一种具有显著光热转换能力的多功能材料.
它通过解决缺氧,细菌感染和炎症,有效地改善糖尿病伤口的微环境.
这种水凝为治疗具有挑战性的糖尿病伤口提供了一个有希望的替代方案.

关键词:

它具有抗菌活性,具有抗菌活性.它具有抗氧化作用的抗氧化作用.改善缺氧的情况.多功能光热水凝多功能光热水凝聚多巴胺纳米颗粒聚多巴胺纳米粒子

更多相关视频

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

相关概念视频

Glucose Absorption Into the Small Intestine

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Microbial Biosensors

Microbial Biosensors

Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...

Hypoglycemia

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...